Compare LAZ & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LAZ | MMSI |
|---|---|---|
| Founded | 1848 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.0B |
| IPO Year | 2004 | 1996 |
| Metric | LAZ | MMSI |
|---|---|---|
| Price | $49.05 | $70.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | $52.75 | ★ $100.38 |
| AVG Volume (30 Days) | ★ 1.3M | 595.7K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.14% | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | ★ 2.17 | 2.13 |
| Revenue | ★ $3,186,466,000.00 | $1,515,906,000.00 |
| Revenue This Year | $14.52 | $8.78 |
| Revenue Next Year | $13.08 | $5.76 |
| P/E Ratio | ★ $22.29 | $32.91 |
| Revenue Growth | 1.48 | ★ 11.75 |
| 52 Week Low | $33.45 | $66.34 |
| 52 Week High | $58.75 | $99.26 |
| Indicator | LAZ | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 63.42 | 52.16 |
| Support Level | $47.92 | $66.76 |
| Resistance Level | $52.41 | $71.57 |
| Average True Range (ATR) | 2.08 | 1.75 |
| MACD | 1.09 | 0.66 |
| Stochastic Oscillator | 81.90 | 79.80 |
Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.